Literature DB >> 12368614

The fate of mastoid obliteration tissue: a histopathological study.

Fred H Linthicum1.   

Abstract

OBJECTIVES: To demonstrate the histopathological fate of tissues used for mastoid obliteration over a period of 30 years. STUDY
DESIGN: Retrospective histopathological analysis of archival temporal bone microscopic sections.
METHODS: From the database of the laboratory, the 17 temporal bones from subjects who had undergone mastoid obliteration procedures were identified. The microscopic appearance of the obliteration tissue was described, and microphotographs made of significant findings.
RESULTS: Fat and bone chips, or paté, retained their bulk in the obliterated space, whereas subcutaneous tissue and muscle lost bulk but seemed to promote healing. Some substances, such as bone wax, used for hemostasis and buried under obliteration tissue, were found to produce a subclinical inflammatory reaction, but other materials, such as Surgicel and Gelfoam, did not.
CONCLUSIONS: Fat and bone chips, or paté, used as mastoid obliteration tissue, retained their bulk and identity, whereas subcutaneous tissue and muscle did not.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368614     DOI: 10.1097/00005537-200210000-00013

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  11 in total

1.  Bioactive glass obliteration of the mastoid significantly improves surgical outcome in non-cholesteatomatous chronic otitis media patients.

Authors:  Joris Vos; Pieter de Vey Mestdagh; David Colnot; Pepijn Borggreven; Claudia Orelio; Jasper Quak
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-27       Impact factor: 2.503

2.  Impact of the surgical wound closure technique on the revision surgery rate after subtotal petrosectomy.

Authors:  Stefan Lyutenski; Burkard Schwab; Thomas Lenarz; Rolf Salcher; Omid Majdani
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-25       Impact factor: 2.503

3.  Single flap with three pedicles, bone paté and split-thickness skin graft for immediate mastoid obliteration after canal wall down mastoidectomy.

Authors:  Khaled M Mokbel; Yasser W Khafagy
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-30       Impact factor: 2.503

4.  The effects of bone pâté on human osteoblasts cell cultures.

Authors:  Nicola Quaranta; Cinzia Buccoliero; Concetta De Luca; Giorgio Mori; Giacomina Brunetti; Silvia Colucci; Graziana Colaianni; Maria Grano
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-02       Impact factor: 2.503

5.  Multilateral scrutiny of the Gülhane mastoidectomy.

Authors:  Mustafa Kahramanyol; Davut Aktaş; Cevat Uçar; Sertaç Yetişer
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-03-15       Impact factor: 2.503

6.  Implantation of the Bonebridge BCI 602 after Mastoid Obliteration with S53P4 Bioactive Glass: A Safe Method of Treating Difficult Anatomical Conditions-Preliminary Results.

Authors:  Bartłomiej Król; Katarzyna Beata Cywka; Magdalena Beata Skarżyńska; Piotr Henryk Skarżyński
Journal:  Life (Basel)       Date:  2021-04-22

Review 7.  Mastoid Obliteration with Autologous Bone in Mastoidectomy Canal Wall Down Surgery: a Literature Overview.

Authors:  Ricardo Dourado Alves; Francisco Cabral Junior; Anna Carolina de Oliveira Fonseca; Ricardo Ferreira Bento
Journal:  Int Arch Otorhinolaryngol       Date:  2015-08-24

8.  Mastoid Obliteration with S53P4 Bioactive Glass Can Make Bonebridge Implantation Feasible: A Case Report.

Authors:  Bartłomiej Król; Marek Porowski; Katarzyna B Cywka; Magdalena B Skarżyńska; Piotr Henryk Skarżyński
Journal:  Am J Case Rep       Date:  2020-11-10

9.  Obliteration of Radical Cavities and Total Reconstruction Procedure Without Staging After Canal Wall Down Mastoidectomy: Long-term Results.

Authors:  Shao-Cheng Liu; Chih-Hung Wang; Bor-Rong Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-08-13       Impact factor: 3.372

10.  Outcomes of Modified Canal Wall Down Mastoidectomy and Mastoid Obliteration Using Autologous Materials.

Authors:  Bo Gyung Kim; Hyo Jun Kim; Seung Jae Lee; Eunsang Lee; Se A Lee; Jong Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2019-02-01       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.